Skip to menu Skip to content Skip to footer

2014

Journal Article

Osteogenesis imperfecta: Diagnosis and treatment

Biggin, A. and Munns, C. F. (2014). Osteogenesis imperfecta: Diagnosis and treatment. Current Osteoporosis Reports, 12 (3), 279-288. doi: 10.1007/s11914-014-0225-0

Osteogenesis imperfecta: Diagnosis and treatment

2014

Journal Article

Fracture during intravenous bisphosphonate treatment in a child with osteogenesis imperfecta: An argument for a more frequent, low-dose treatment regimen

Biggin, Andrew, Briody, Julie N., Ormshaw, Elizabeth, Wong, Karen K.Y., Bennetts, Bruce H. and Munns, Craig F. (2014). Fracture during intravenous bisphosphonate treatment in a child with osteogenesis imperfecta: An argument for a more frequent, low-dose treatment regimen. Hormone Research in Paediatrics, 81 (3), 204-210. doi: 10.1159/000355111

Fracture during intravenous bisphosphonate treatment in a child with osteogenesis imperfecta: An argument for a more frequent, low-dose treatment regimen

2014

Journal Article

Use of bisphosphonates in children: Authors' reply

Bhatt, Reena, Hibbert, Sally and Munns, Craig (2014). Use of bisphosphonates in children: Authors' reply. Australian Dental Journal, 59 (3), 405-406. doi: 10.1111/adj.12208

Use of bisphosphonates in children: Authors' reply

2014

Journal Article

CHARGE syndrome: A review

Hsu, Peter, Ma, Alan, Wilson, Meredith, Williams, George, Curotta, John, Munns, Craig F and Mehr, Sam (2014). CHARGE syndrome: A review. Journal of Paediatrics and Child Health, 50 (7), 504-511. doi: 10.1111/jpc.12497

CHARGE syndrome: A review

2014

Journal Article

Fracture prediction and the definition of osteoporosis in children and adolescents: The ISCD 2013 pediatric official positions

Bishop, Nick, Arundel, Paul, Clark, Emma, Dimitri, Paul, Farr, Joshua, Jones, Graeme, Makitie, Outi, Munns, Craig F. and Shaw, Nick (2014). Fracture prediction and the definition of osteoporosis in children and adolescents: The ISCD 2013 pediatric official positions. Journal of Clinical Densitometry, 17 (2), 275-280. doi: 10.1016/j.jocd.2014.01.004

Fracture prediction and the definition of osteoporosis in children and adolescents: The ISCD 2013 pediatric official positions

2014

Journal Article

Vitamin D supplementation and the effects on glucose metabolism during pregnancy: A randomized controlled trial

Yap, Constance, Cheung, N. Wah, Gunton, Jenny E., Athayde, Neil, Munns, Craig F., Duke, Anna and McLean, Mark (2014). Vitamin D supplementation and the effects on glucose metabolism during pregnancy: A randomized controlled trial. Diabetes Care, 37 (7), 1837-1844. doi: 10.2337/dc14-0155

Vitamin D supplementation and the effects on glucose metabolism during pregnancy: A randomized controlled trial

2013

Journal Article

Evaluation of bone mineral density and morphology using pQCT in children after spinal cord injury

Biggin, Andrew, Briody, Julie N., Ramjan, Kim A., Middleton, Anna, Waugh, Mary-Clare A. and Munns, Craig F. (2013). Evaluation of bone mineral density and morphology using pQCT in children after spinal cord injury. Developmental Neurorehabilitation, 16 (6), 391-397. doi: 10.3109/17518423.2012.762590

Evaluation of bone mineral density and morphology using pQCT in children after spinal cord injury

2013

Journal Article

Intravenous zoledronic acid given every 6 months in childhood osteoporosis

Ooi, Hooi Leng, Briody, Julie, Biggin, Andrew, Cowell, Chris T. and Munns, Craig F. (2013). Intravenous zoledronic acid given every 6 months in childhood osteoporosis. Hormone Research in Paediatrics, 80 (3), 179-184. doi: 10.1159/000354303

Intravenous zoledronic acid given every 6 months in childhood osteoporosis

2013

Journal Article

Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: A retrospective analysis

Padhye, Bhavna, Dalla-Pozza, Luciano, Little, David G. and Munns, Craig F. (2013). Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: A retrospective analysis. Pediatric Blood and Cancer, 60 (9), 1539-1545. doi: 10.1002/pbc.24563

Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: A retrospective analysis

2013

Journal Article

Exercise in children with joint hypermobility syndrome and knee pain: A randomised controlled trial comparing exercise into hypermobile versus neutral knee extension

Pacey, Verity, Tofts, Louise, Adams, Roger D., Munns, Craig F. and Nicholson, Leslie L. (2013). Exercise in children with joint hypermobility syndrome and knee pain: A randomised controlled trial comparing exercise into hypermobile versus neutral knee extension. Pediatric Rheumatology, 11 (1) 30. doi: 10.1186/1546-0096-11-30

Exercise in children with joint hypermobility syndrome and knee pain: A randomised controlled trial comparing exercise into hypermobile versus neutral knee extension

2013

Journal Article

Intravenous pamidronate treatment in children with moderate-to-severe osteogenesis imperfecta started under three years of age

Alcausin, M. B., Briody, J., Pacey, V., Ault, J., McQuade, M., Bridge, C., Engelbert, R. H.H., Sillence, D. O. and Munns, C. F. (2013). Intravenous pamidronate treatment in children with moderate-to-severe osteogenesis imperfecta started under three years of age. Hormone Research in Paediatrics, 79 (6), 333-340. doi: 10.1159/000351374

Intravenous pamidronate treatment in children with moderate-to-severe osteogenesis imperfecta started under three years of age

2013

Journal Article

Vitamin D and health in pregnancy, infants, children and adolescents in Australia and New Zealand: a position statement

Paxton, Georgia A., Teale, Glyn R., Nowson, Caryl A., Mason, Rebecca S., McGrath, John J., Thompson, Melanie J., Siafarikas, Aris, Rodda, Christine P. and Munns, Craig F. (2013). Vitamin D and health in pregnancy, infants, children and adolescents in Australia and New Zealand: a position statement. Medical Journal of Australia, 198 (3), 1-8. doi: 10.5694/mja11.11592

Vitamin D and health in pregnancy, infants, children and adolescents in Australia and New Zealand: a position statement

2013

Journal Article

The impact of dysglycaemia on bone mineral accrual in young people with cystic fibrosis

Rana, Malay, Munns, Craig F., Selvadurai, Hiran, Briody, Julie and Craig, Maria E. (2013). The impact of dysglycaemia on bone mineral accrual in young people with cystic fibrosis. Clinical Endocrinology, 78 (1), 36-42. doi: 10.1111/j.1365-2265.2012.04484.x

The impact of dysglycaemia on bone mineral accrual in young people with cystic fibrosis

2013

Journal Article

Risedronate in children with osteogenesis imperfecta: A randomised, double-blind, placebo-controlled trial

Bishop, Nick, Adami, Silvano, Ahmed, S Faisal, Antón, Jordi, Arundel, Paul, Burren, Christine P., Devogelaer, Jean-Pierre, Hangartner, Thomas, Hosszú, Eva, Lane, Joseph M, Lorenc, Roman, Mäkitie, Outi, Munns, Craig F, Paredes, Ana, Pavlov, Helene, Plotkin, Horacio, Raggio, Cathleen L., Reyes, Maria Loreto, Schoenau, Eckhard, Semler, Oliver, Sillence, David O. and Steiner, Robert D. (2013). Risedronate in children with osteogenesis imperfecta: A randomised, double-blind, placebo-controlled trial. The Lancet, 382 (9902), 1424-1432. doi: 10.1016/S0140-6736(13)61091-0

Risedronate in children with osteogenesis imperfecta: A randomised, double-blind, placebo-controlled trial

2012

Journal Article

Stability of oral cholecalciferol (vitamin D3) liquid formulations in Olive oil

Joseph, Pathma D., Hemmens, Violet J. and Munns, Craig F. (2012). Stability of oral cholecalciferol (vitamin D3) liquid formulations in Olive oil. Journal of Pharmacy Practice and Research, 42 (3), 213-217. doi: 10.1002/j.2055-2335.2012.tb00173.x

Stability of oral cholecalciferol (vitamin D3) liquid formulations in Olive oil

2012

Journal Article

Zoledronic acid improves bone mineral density in pediatric spinal cord injury

Ooi, Hooi Leng, Briody, Julie, McQuade, Mary and Munns, Craig F. (2012). Zoledronic acid improves bone mineral density in pediatric spinal cord injury. Journal of Bone and Mineral Research, 27 (7), 1536-1540. doi: 10.1002/jbmr.1598

Zoledronic acid improves bone mineral density in pediatric spinal cord injury

2012

Journal Article

Incidence of vitamin D deficiency rickets among Australian children: An Australian Paediatric Surveillance Unit study

Munns, Craig F., Simm, Peter J., Rodda, Christine P., Garnett, Sarah P., Zacharin, Margaret R., Ward, Leanne M., Geddes, Janet, Cherian, Sarah, Zurynski, Yvonne and Cowell, Christopher T (2012). Incidence of vitamin D deficiency rickets among Australian children: An Australian Paediatric Surveillance Unit study. Medical Journal of Australia, 196 (7), 466-468. doi: 10.5694/mja11.10662

Incidence of vitamin D deficiency rickets among Australian children: An Australian Paediatric Surveillance Unit study

2012

Journal Article

Consensus statement on standard of care for congenital myopathies

Wang, Ching H., Dowling, James J., North, Kathryn, Schroth, Mary K., Sejersen, Thomas, Shapiro, Frederic, Bellini, Jonathan, Weiss, Hali, Guillet, Marc, Amburgey, Kimberly, Apkon, Susan, Bertini, Enrico, Bonnemann, Carsten, Clarke, Nigel, Connolly, Anne M., Estournet-Mathiaud, Brigitte, Fitzgerald, Dominic, Florence, Julaine M., Gee, Richard, Gurgel-Giannetti, Juliana, Glanzman, Allan M., Hofmeister, Brittany, Jungbluth, Heinz, Koumbourlis, Anastassios C., Laing, Nigel G., Main, Marion, Morrison, Leslie A., Munns, Craig, Rose, Kristy ... Yuan, Nanci (2012). Consensus statement on standard of care for congenital myopathies. Journal of Child Neurology, 27 (3), 363-382. doi: 10.1177/0883073812436605

Consensus statement on standard of care for congenital myopathies

2012

Journal Article

Recombinant parathyroid hormone therapy for severe neonatal hypoparathyroidism

Cho, Yoon Hi, Tchan, Michel, Roy, Bithi, Halliday, Robert, Wilson, Meredith, Dutt, Shoma, Siew, Susan, Munns, Craig and Howard, Neville (2012). Recombinant parathyroid hormone therapy for severe neonatal hypoparathyroidism. Journal of Pediatrics, 160 (2), 345-348. doi: 10.1016/j.jpeds.2011.09.022

Recombinant parathyroid hormone therapy for severe neonatal hypoparathyroidism

2011

Journal Article

Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2years of treatment in children with secondary osteoporosis

Simm, Peter J., Johannesen, Jesper, Briody, Julie, McQuade, Mary, Hsu, Brian, Bridge, Corinne, Little, David G., Cowell, Christopher T. and Munns, Craig F. (2011). Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2years of treatment in children with secondary osteoporosis. Bone, 49 (5), 939-943. doi: 10.1016/j.bone.2011.07.031

Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2years of treatment in children with secondary osteoporosis